000 01380 a2200409 4500
005 20250517230623.0
264 0 _c20190708
008 201907s 0 0 eng d
022 _a1096-8652
024 7 _a10.1002/ajh.25166
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrunner, Andrew M
245 0 0 _aImpact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes.
_h[electronic resource]
260 _bAmerican journal of hematology
_c09 2018
300 _a1119-1126 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBlood Transfusion
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLenalidomide
_xpharmacology
650 0 4 _aMale
650 0 4 _aMyelodysplastic Syndromes
_xmortality
650 0 4 _aOff-Label Use
650 0 4 _aSurvival Analysis
700 1 _aWeng, Shicheng
700 1 _aCronin, Angel
700 1 _aFathi, Amir T
700 1 _aHabib, Anand R
700 1 _aStone, Richard
700 1 _aGraubert, Tim
700 1 _aSteensma, David P
700 1 _aAbel, Gregory A
773 0 _tAmerican journal of hematology
_gvol. 93
_gno. 9
_gp. 1119-1126
856 4 0 _uhttps://doi.org/10.1002/ajh.25166
_zAvailable from publisher's website
999 _c28657318
_d28657318